Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma

S E Krown1

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. krowns@mskcc.org

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|May 6, 1998
PubMed
Summary

Interferon-alpha (IFN-alpha) has evolved as a treatment for Kaposi

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Kaposi sarcoma: the role of interferon and thalidomide.

Current opinion in oncology·2001
Same author

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same author

Clinical overview: issues in Kaposi's sarcoma therapeutics.

Journal of the National Cancer Institute. Monographs·1998
Same author

Phase I/II trial of the type I soluble recombinant human interleukin-1 receptor in HIV-1-infected patients.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·1998
Same author

Management of AIDS-associated Kaposi's sarcoma: a multidisciplinary perspective.

Oncology (Williston Park, N.Y.)·1998
Same author

AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Kaposi's sarcoma (KS) treatment in acquired immunodeficiency syndrome (AIDS) patients has evolved significantly over 15 years.
  • Early interferon-alpha (IFN-alpha) success predated human immunodeficiency virus (HIV) identification and a clear understanding of KS.

Purpose of the Study:

  • To review the advancements in IFN-alpha therapy for AIDS-associated KS.
  • To explore how improved understanding of AIDS, KS, and IFN-alpha biology impacts treatment.

Main Methods:

  • Review of scientific literature and clinical data spanning approximately 15 years.
  • Analysis of the interplay between HIV infection, KS pathogenesis, and IFN-alpha treatment efficacy.

Main Results:

  • IFN-alpha therapy for KS has become more rational and successful with increased biological and clinical knowledge.
  • Advances in HIV treatment and understanding of KS biology have enhanced IFN-alpha's role.

Conclusions:

  • Current IFN-alpha outcomes for KS can be further improved.
  • Future strategies should integrate advanced HIV therapies and anti-angiogenic cytokine inhibitors.

Related Experiment Videos